Marinus Pharmaceuticals, Inc. ( MRNS) - Key Metrics
Stock symbol MRNS is outdated, potentially delisted? Maybe it is available on other exchange?
MRNS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | $0.15 | -$0.42 | -$0.34 | -$0.36 |
| 2024Q2 | $0.14 | -$0.63 | -$0.54 | -$0.54 |
| 2024Q1 | $0.14 | -$0.68 | -$0.66 | -$0.66 |
| 2023Q4 | $0.13 | -$0.74 | -$0.48 | -$0.48 |
| 2023Q3 | $0.14 | -$0.61 | -$0.47 | -$0.47 |
MRNS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | -1.04 |
| 2024Q2 | ? | -0.51 |
| 2024Q1 | ? | -3.30 |
| 2023Q4 | ? | -3.69 |
| 2023Q3 | ? | -3.29 |
MRNS
Price: $0.55
52 week price:
Earnings Per Share: -2.47 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 214200
Ebitda: -19.9 millionMarket Capitalization: 30.4 million